Mikel San-Julian

Summary

Affiliation: University of Navarra
Country: Spain

Publications

  1. ncbi request reprint [Bone transplant]
    M San Julian
    Departamento de Cirugia Ortopedica y Traumatologia, Clinica Universitaria de Navarra, 31008, Pamplona, Spain
    An Sist Sanit Navar 29:125-36. 2006
  2. ncbi request reprint Indications for epiphyseal preservation in metaphyseal malignant bone tumors of children: relationship between image methods and histological findings
    M San-Julian
    Department of Orthopaedics, University of Navarra, Pamplona, Spain
    J Pediatr Orthop 19:543-8. 1999
  3. ncbi request reprint Bone metastases from osteosarcoma
    M San-Julian
    Department of Orthopaedics, University Clinic, University of Navarra, 31080 Pamplona, Spain
    Int Orthop 27:117-20. 2003
  4. ncbi request reprint Limb salvage in bone sarcomas in patients younger than age 10: a 20-year experience
    Mikel San-Julian
    Department of Orthopedic, University of Navarra, Pamplona, Spain
    J Pediatr Orthop 23:753-62. 2003
  5. doi request reprint Limb salvage in Ewing's sarcoma of the distal lower extremity
    Mikel San-Julian
    Department of Orthopedic Surgery, University of Navarre, Avd PIO XII 36, 31080 Pamplona, Spain
    Foot Ankle Int 29:22-8. 2008
  6. doi request reprint Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression
    Ana Patino-Garcia
    Laboratory of Pediatrics, University of Navarra University Clinic, Pamplona, Spain
    J Pediatr 154:688-93. 2009
  7. ncbi request reprint A long-term retrospective review of 5 cases using daptomycin for prosthetic device infections after surgery
    Emilio G Quetglas
    Emergency Department, Clinical Pharmacology Service, University Clinic of Navarra, Pamplona
    Int J Artif Organs 32:299-307. 2009
  8. ncbi request reprint Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas
    Rafael Martinez-Monge
    Department of Oncology, University Clinic, University of Navarra, Avda Pío XII s n, Pamplona, E 31080 Navarre, Spain
    Brachytherapy 3:196-200. 2004
  9. doi request reprint Long-term results after resection for soft tissue sarcoma pulmonary metastases
    Carlos E García Franco
    Department of General Thoracic Surgery, Clinica Universidad Navarra, Avenida Pio XII 36, Pamplona 31008, Spain
    Interact Cardiovasc Thorac Surg 9:223-6. 2009
  10. ncbi request reprint Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: alternative to aggressive surgery
    Rafael Martinez-Monge
    Department of Oncology, University of Navarre, Pamplona, Spain
    Brachytherapy 2:114-6. 2003

Collaborators

Detail Information

Publications18

  1. ncbi request reprint [Bone transplant]
    M San Julian
    Departamento de Cirugia Ortopedica y Traumatologia, Clinica Universitaria de Navarra, 31008, Pamplona, Spain
    An Sist Sanit Navar 29:125-36. 2006
    ..In short, the increasingly widespread use of allografts is an essential therapeutic weapon in orthopaedic surgery and traumatology. It must be used by expert hands...
  2. ncbi request reprint Indications for epiphyseal preservation in metaphyseal malignant bone tumors of children: relationship between image methods and histological findings
    M San-Julian
    Department of Orthopaedics, University of Navarra, Pamplona, Spain
    J Pediatr Orthop 19:543-8. 1999
    ..If the tumor shows contact with part of the physis, it is also possible to preserve the epiphysis...
  3. ncbi request reprint Bone metastases from osteosarcoma
    M San-Julian
    Department of Orthopaedics, University Clinic, University of Navarra, 31080 Pamplona, Spain
    Int Orthop 27:117-20. 2003
    ..Those with multiple metastases were treated by palliative measures, and none survived. We conclude that resection of solitary metastases from osteosarcoma after neoadjuvant chemotherapy can be curative...
  4. ncbi request reprint Limb salvage in bone sarcomas in patients younger than age 10: a 20-year experience
    Mikel San-Julian
    Department of Orthopedic, University of Navarra, Pamplona, Spain
    J Pediatr Orthop 23:753-62. 2003
    ..Limb salvage is a real possibility even in young children with bone sarcomas. The age of the patient itself is not a contraindication for limb salvage...
  5. doi request reprint Limb salvage in Ewing's sarcoma of the distal lower extremity
    Mikel San-Julian
    Department of Orthopedic Surgery, University of Navarre, Avd PIO XII 36, 31080 Pamplona, Spain
    Foot Ankle Int 29:22-8. 2008
    ..There are no large series covering this issue. Some authors advise amputation as the "gold standard" treatment. The authors here prsent their experience in limb salvage of fourteen cases of ES in distal lower extremities...
  6. doi request reprint Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression
    Ana Patino-Garcia
    Laboratory of Pediatrics, University of Navarra University Clinic, Pamplona, Spain
    J Pediatr 154:688-93. 2009
    ..To determine the influence of the genotype and the level of expression of different enzymes involved in folate metabolism on the response to and toxicity of high-dose methotrexate treatment in pediatric osteosarcomas...
  7. ncbi request reprint A long-term retrospective review of 5 cases using daptomycin for prosthetic device infections after surgery
    Emilio G Quetglas
    Emergency Department, Clinical Pharmacology Service, University Clinic of Navarra, Pamplona
    Int J Artif Organs 32:299-307. 2009
    ....
  8. ncbi request reprint Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas
    Rafael Martinez-Monge
    Department of Oncology, University Clinic, University of Navarra, Avda Pío XII s n, Pamplona, E 31080 Navarre, Spain
    Brachytherapy 3:196-200. 2004
    ..This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an accelerated boost in patients with pediatric sarcomas...
  9. doi request reprint Long-term results after resection for soft tissue sarcoma pulmonary metastases
    Carlos E García Franco
    Department of General Thoracic Surgery, Clinica Universidad Navarra, Avenida Pio XII 36, Pamplona 31008, Spain
    Interact Cardiovasc Thorac Surg 9:223-6. 2009
    ..The overall five-year survival rate was 23.1%. DFI, number of lung nodules at surgery and metastatic histology are significant prognostic factors for patients with resected pulmonary metastases from STS...
  10. ncbi request reprint Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: alternative to aggressive surgery
    Rafael Martinez-Monge
    Department of Oncology, University of Navarre, Pamplona, Spain
    Brachytherapy 2:114-6. 2003
    ..The patient died 11 months after surgery without signs or symptoms of bony damage and retained the ability to walk for the remainder of her life...
  11. ncbi request reprint Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study
    Rafael Martinez-Monge
    Department of Oncology, University of Navarra Clinic, University of Navarra, Pamplona, Spain
    Brachytherapy 4:264-70. 2005
    ..This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an alternative to standard low-dose-rate brachytherapy in adult patients with soft tissue sarcomas...
  12. doi request reprint Long-term results after resection for bone sarcoma pulmonary metastases
    Carlos E García Franco
    Department of General Thoracic Surgery, Clinica Universidad de Navarra, Pamplona, Spain
    Eur J Cardiothorac Surg 37:1205-8. 2010
    ..The combination of both chemotherapy and surgical resection is currently the standard treatment options for these patients. We aim to study the influence of different prognostic factors on long-term survival...
  13. pmc Nonreferral of possible soft tissue sarcomas in adults: a dangerous omission in policy
    Juan F Abellan
    Department of Orthopedic Surgery, University of Navarra, 31080 Pamplona, Spain
    Sarcoma 2009:827912. 2009
    ..The influence on outcome of initial wide local excision (WLE), which is made possible by referral to a specialist centre, is paramount...
  14. doi request reprint Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets
    Cecilia Folio
    Department of Pediatrics, University Clinic of Navarra, Pamplona, Spain
    J Proteome Res 8:3882-8. 2009
    ....
  15. doi request reprint Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Ana Patino-Garcia
    Laboratories of Pediatrics, University Hospital, University of Navarra, Pamplona, Spain
    Clin Cancer Res 15:5082-91. 2009
    ..At present, the mechanisms of initiation, maintenance, and metastasis are poorly understood. The purpose of this study was to identify relevant molecular targets in the pathogenesis of osteosarcoma...
  16. ncbi request reprint Use of brachytherapy in children with cancer: the search for an uncomplicated cure
    Rafael Martinez-Monge
    Radiation Oncology Division, Department of Oncology, Clinica Universitaria, University of Navarra, Pamplona, Spain
    Lancet Oncol 7:157-66. 2006
    ....
  17. ncbi request reprint Periosteal osteosarcoma--a European review of outcome
    Robert J Grimer
    The Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, UK
    Eur J Cancer 41:2806-11. 2005
    ..Survival was related to appearance of local recurrence (P < 0.0001) but no other single factor. The use of chemotherapy was not shown to be a prognostic factor, but was used in two-thirds of the patients in this study...
  18. ncbi request reprint Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group
    Robert J Grimer
    Royal Orthopaedic Hospital, Bristol Road South, Birmingham B31 2AP, UK
    Eur J Cancer 43:2060-5. 2007
    ..Because of its rarity, there are few large studies of outcome which might identify potential prognostic factors. In particular there remains uncertainty about the value of chemotherapy for this condition...